| 000 | 01765 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516015142.0 | ||
| 264 | 0 | _c20110214 | |
| 008 | 201102s 0 0 eng d | ||
| 022 | _a1090-2104 | ||
| 024 | 7 |
_a10.1016/j.bbrc.2010.12.051 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKarczewska, Joanna | |
| 245 | 0 | 0 |
_aPurinergic modulation of glucose uptake into cultured rat podocytes: effect of diabetic milieu. _h[electronic resource] |
| 260 |
_bBiochemical and biophysical research communications _cJan 2011 |
||
| 300 |
_a723-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xanalogs & derivatives |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiological Transport _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDeoxyglucose _xmetabolism |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucose _xmetabolism |
| 650 | 0 | 4 |
_aPodocytes _xmetabolism |
| 650 | 0 | 4 |
_aPurinergic P2 Receptor Agonists _xpharmacology |
| 650 | 0 | 4 |
_aPurinergic P2Y Receptor Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aPyridoxal Phosphate _xanalogs & derivatives |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReceptors, Purinergic P2 _xmetabolism |
| 650 | 0 | 4 |
_aSuramin _xpharmacology |
| 650 | 0 | 4 |
_aThionucleotides _xpharmacology |
| 650 | 0 | 4 |
_aTriazines _xpharmacology |
| 700 | 1 | _aPiwkowska, Agnieszka | |
| 700 | 1 | _aRogacka, Dorota | |
| 700 | 1 | _aStępiński, Jan | |
| 700 | 1 | _aAngielski, Stefan | |
| 700 | 1 | _aJankowski, Maciej | |
| 773 | 0 |
_tBiochemical and biophysical research communications _gvol. 404 _gno. 2 _gp. 723-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbrc.2010.12.051 _zAvailable from publisher's website |
| 999 |
_c20452144 _d20452144 |
||